322
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies

, , , , , , & show all
Pages 2465-2473 | Received 27 Feb 2012, Accepted 08 May 2012, Published online: 18 Jun 2012

References

  • Ausserlechner MJ, Obexer P, Bock G, . Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells. Cell Death Differ 2004;11:165–174.
  • Tissing WJ, Meijerink JP, den Boer ML, . Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003;17:17–25.
  • Ploner C, Schmidt S, Presul E, . Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid Biochem Mol Biol 2005;93:153–160.
  • Pui CH. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program 2006:142–146.
  • Pieters R, Klumper E, Kaspers GJ, . Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol 1997;25:11–26.
  • Schrappe M, Reiter A, Zimmermann M, . Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000;14:2205–2222.
  • Anderson MJ, Viars CS, Czekay S, . Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 1998;47:187–199.
  • Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007;7:847–859.
  • Paik JH, Kollipara R, Chu G, . FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007;128:309–323.
  • Dijkers PF, Medema RH, Pals C, . Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 2000;20:9138–9148.
  • Schmidt M, Fernandez DMS, van der Horst A, . Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 2002;22:7842–7852.
  • Ramaswamy S, Nakamura N, Sansal I, . A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002;2:81–91.
  • Brunet A, Bonni A, Zigmond MJ, . Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857–868.
  • Ghaffari S, Jagani Z, Kitidis C, . Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor. Proc Natl Acad Sci USA 2003;100:6523–6528.
  • Dijkers PF, Medema RH, Lammers JW, . Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000;10:1201–1204.
  • Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003;162:613–622.
  • Essafi A, Fernandez DMS, Hassen YA, . Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 2005;24:2317–2329.
  • Tang TT, Dowbenko D, Jackson A, . The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 2002;277:14255–14265.
  • Hu MC, Lee DF, Xia W, . IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004; 117:225–237.
  • Yang JY, Zong CS, Xia W, . ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008;10:138–148.
  • Kornblau SM, Singh N, Qiu Y, . Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia. Clin Cancer Res 2010;16:1865–1874.
  • Frankfurt O, Rosen ST. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004;16:553–563.
  • Ma J, Xie Y, Shi Y, . Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem Biophys Res Commun 2008;377:894–898.
  • Elia L, Contu R, Quintavalle M, . Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009;120:2377–2385.
  • Kong W, He L, Coppola M, . MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010;285:17869–17879.
  • Segura MF, Hanniford D, Menendez S, . Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 2009;106:1814–1819.
  • Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215–233.
  • Lagos-Quintana M, Rauhut R, Lendeckel W, . Identification of novel genes coding for small expressed RNAs. Science 2001;294:853–858.
  • Lau NC, Lim LP, Weinstein EG, . An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001;294:858–862.
  • Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843–854.
  • Calin GA, Ferracin M, Cimmino A, . A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793–1801.
  • Calin GA, Dumitru CD, Shimizu M, . Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99: 15524–15529.
  • Johnson SM, Grosshans H, Shingara J, . RAS is regulated by the let-7 microRNA family. Cell 2005;120:635–647.
  • Eis PS, Tam W, Sun L, . Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005;102: 3627–3632.
  • Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005;65: 6029–6033.
  • He L, Thomson JM, Hemann MT, . A microRNA polycistron as a potential human oncogene. Nature 2005;435:828–833.
  • Balatti V, Maniero S, Ferracin M, . MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol 2011;6: 844–851.
  • Vaksman O, Stavnes HT, Kaern J, . miRNA profiling along tumor progression in ovarian carcinoma. J Cell Mol Med 2011;15:1593–1602.
  • Yin Y, Li M, Li H, . [Expressions of 6 microRNAs in prostate cancer]. Zhonghua Nan Ke Xue 2010;16:599–605.
  • Schaefer A, Jung M, Mollenkopf HJ, . Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010;126:1166–1176.
  • Han Y, Chen J, Zhao X, . MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 2011;6:e18286.
  • Sun Y, Fang R, Li C, . Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 2010;396:501–507.
  • Barshack I, Lithwick-Yanai G, Afek A, . MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract 2010;206:578–584.
  • Myatt SS, Wang J, Monteiro LJ, . Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 2010;70:367–377.
  • Sarver AL, French AJ, Borralho PM, . Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009;9:401.
  • Hannafon BN, Sebastiani P, de Las MA, . Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res 2011;13:R24.
  • Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009;284:23204–23216.
  • Bruchova H, Merkerova M, Prchal JT. Aberrant expression of microRNA in polycythemia vera. Haematologica 2008;93: 1009–1016.
  • Zhang H, Luo XQ, Zhang P, . MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 2009;4:e7826.
  • Dai R, Zhang Y, Khan D, . Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 2010;5:e14302.
  • Varkonyi-Gasic E, Wu R, Wood M, . Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 2007;3:12.
  • Pogribny IP, Muskhelishvili L, Tryndyak VP, . The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol Appl Pharmacol 2009;235:305–311.
  • Gokhale A, Kunder R, Goel A, . Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther 2010;6:521–529.
  • Sacheli R, Nguyen L, Borgs L, . Expression patterns of miR-96, miR-182 and miR-183 in the development inner ear. Gene Expr Patterns 2009;9:364–370.
  • Soukup GA. Little but loud: small RNAs have a resounding affect on ear development. Brain Res 2009;1277:104–114.
  • Moskwa P, Buffa FM, Pan Y, . miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 2011;41:210–220.
  • Yao E, Ventura A. A new role for miR-182 in DNA repair. Mol Cell 2011;41:135–137.
  • Jiang L, Mao P, Song L, . miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 2010;177: 29–38.
  • Hulleman E, Kazemier KM, Holleman A, . Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood 2009;113:2014–2021.
  • Bachmann PS, Gorman R, Mackenzie KL, . Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor. Blood 2005;105:2519–2526.
  • Tessel MA, Benham AL, Krett NL, . Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma. Horm Cancer 2011;2:182–189.
  • Kotani A, Ha D, Hsieh J, . miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood 2009;114:4169–4178.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.